Clinical Trial Trends – A look back at 2016

08 May

Clinical Trial Trends – A look back at 2016

by Shweta Mishra

2016 was an exciting year for clinical research and drug development. With the backing of big research initiatives like the federally funded Cancer Moonshot, clinical research kicked off on the path of groundbreaking developments. mHealth continued to dominate health technology trend last year, with ResearchKit enabled apps breathing momentum into research study recruitment and consent efforts. However, FDA approved drug numbers continue to point towards the stringent FDA approval process and failed trials brought down sponsor stock prices this year too!

 

Clinical Trials Trends - A look back at 2016

 

Shweta Mishra
Shweta Mishra
shweta@trialx.com

Shweta is responsible for research support, digital marketing and content initiatives at Applied Informatics/TrialX. A San Jose State University Graduate, she holds dual masters degree in Biochemistry and Nutrition Science, and is passionate about the science behind the diverse life phenomenas. She also holds certifications in Digital Marketing from Hubspot Academy, Protecting Human Research Participants from NIH and in Intellectual Property in Biotechnology from WIPO. At TrialX CureTalks she hosts women's health/infertility/reproductive medicine talk series driven by her personal experiences.

No Comments

Sorry, the comment form is closed at this time.

Shares